Incorporation of all-trans retinoic acid into lipoplexes inhibits nuclear factor κB activation mediated liver injury induced by lipoplexes in mice

Journal of Gene Medicine

Volumn 10, Issue 1, 2008, Pages 61-69

  Charoensit, Pensri ^a   Kawakami, Shigeru ^a   Higuchi, Yuriko ^a   Hashida, Mitsuru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

ATRA; Gene therapy; Lipoplexes; NF B; Toxicity

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; ALANINE AMINOTRANSFERASE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPLEX; LIPOSOME; RETINOIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HISTOPATHOLOGY; LIVER INJURY; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TISSUE DISTRIBUTION; ZETA POTENTIAL;

ALANINE TRANSAMINASE; ANIMALS; DNA; FEMALE; GENE EXPRESSION PROFILING; INJECTIONS, INTRAVENOUS; INTERLEUKIN-6; LIPOSOMES; LIVER DISEASES; MICE; MICE, INBRED ICR; NF-KAPPA B; ORGAN SPECIFICITY; PARTICLE SIZE; PHOSPHORUS RADIOISOTOPES; TRETINOIN; TRITIUM; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 38349166627     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1117     Document Type: Article

References (30)

1. Hansen LA, Sigman CC, Andreola F, Ross SA, Kelloff GJ, De Luca LM. Retinoids in chemoprevention and differentiation therapy. Carcinogenesis 2000; 21: 1271-1279.
2. Datta PK, Lianos EA. Retinoic acids inhibit inducible nitric oxide synthase expression in mesangial cells. Kidney Int 1999; 56: 486-493.
3. Kim BH, Kang KS, Lee YS. Effect of retinoids on LPS-induced COX-2 expression and COX-2 associated PGE(2) release from mouse peritoneal macrophages and TNF-α release from rat peripheral blood mononuclear cells. Toxicol Lett 2004; 150: 191-201.
4. Austenaa LM, Carlsen H, Ertesvag A, Alexander G, Blomhoff HK, Blomhoff R. Vitamin A status significantly alters nuclear factor-kappaB activity assessed by in vivo imaging. FASEB J 2004; 18: 1255-1257.
5. Motomura K, Sakai H, Isobe H, Nawata H. All-trans retinoic acid suppresses liver injury induced by Propionibacterium acnes and lipopolysaccharide in rats. J Gastrol Hepatol Commun 1997; 5: 177-183.
6. Oseto S, Moriyama T, Kawada N, et al. Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis. Kidney Int 2003; 64: 1241-1252.
7. Muindi JR, Frankel SR, Huselton C, et al. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res 1992; 52: 2138-21342.
8. Nozaki Y, Yamgata T, Sugiyama M, Ikoma S, Kinoshita K, Funauchi M. Anti-inflammatory effect of all-trans-retinoic acid in inflammatory arthritis. Clin Immunol 2006; 119: 272-279.
9. Liu F, Qi H, Huang L, Liu D. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration. Gene Ther 1997; 4: 517-523.
10. Song YK, Liu F, Liu D. Enhanced gene expression in mouse lung by prolonging the retention time of intravenously injected plasmid DNA. Gene Ther 1998; 5: 1531-1537.
11. Sakurai F, Terada T, Yasuda K, Yamashita F, Takakura Y, Hashida M. The role of tissue macrophages in the induction of proinflammatory cytokine production following intravenous injection of lipoplexes. Gene Ther 2002; 9: 1120-1126.
12. Dow S, Elmslie R, Kurzman I, Macewen G, Pericle F, Liggitt DH. Phase I study of liposome-DNA complexes encoding the interleukin-2 gene in dogs with osteosarcoma lung metastases. Hum Gene Ther 2005; 16: 937-946.
13. Mahato RI, Kawabata K, Nomura T, Takakura Y, Hashida M. Physicochernical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes. J Pharm Sci 1995; 84: 1267-1271.
14. Tousignant JD, Gates AL, Ingram LA, et al. Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid: plasmid DNA complexes in mice. Hum Gene Ther 2000; 11: 2493-2513.
15. Kawakami S, Ito Y, Charoensit P, Yamashita F, Hashida M. Evaluation of proinflammatory cytokine production induced by linear and branched polyethylenimine/plasmid DNA complexes in mice. J Pharmacol Exp Ther 2006; 317: 1382-1399.
16. Loisel S, Le Gall C, Doucet L, Ferec C, Floch V. Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes. Hum Gene Ther 2001; 12: 685-696.
17. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immurrol 2002; 20: 709-760.
18. Takino T, Nagahama E, Sakaeda T, Yamashita F, Takakura Y, Hashida M. Pharmacokinetic disposition analysis of lipophilic drugs injected with various lipid carriers in the single-pass rat liver perfusion system. Int J Pharm 1995; 114: 43-54.
19. Kawakami S, Suzuki S, Yamashita F, Hashida M. Induction of apoptosis in A549 human lung cancer cells by all-trans retinoic acid incorporated in DOTAP/cholesterol liposomes. J Control Release 2006; 110: 514-521.
20. Suzuki S, Kawakami S, Chansri N, Yamashita F, Hashida M. Inhinition of pulmonary metastasis in mice by all-trans retinoic acid incorporated in cationic liposomes. J Control Release 2006; 116: 58-63.
21. Higuchi Y. Kawakami S. Oka M, Yabe Y, Yamashita F, Hashida M. Intravenous administration of mannosylated cationic liposome/NFkappaB decoy complexes effectively prevent LPS-induced cytokine production in a murine liver failure model. FEBS Lett 2006; 580: 3706-3714.
22. Tan Y, Zhang JS, Huang L. Codelivery of NF-κB decoy-related oligodeoxynudeotide improves LPD-mediated systemic gene transfer. Mol Ther 2002; 6: 804-812.
23. McLachlan G, Stevenson BJ, Davidson DJ, Porteous DJ. Bacterial DNA is implicated in the inflammatory response to delivery of DNA/DOTAP to mouse lungs. Gene Ther 2000; 7: 384-392.
24. Ramesh R, Saeki T, Templeton NS, et al. Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector. Mol Ther 2001; 3: 337-350.
25. Sakurai F, Inoue R, Nishino Y, et al. Effect of DNA/liposome mixing ratio on the physicochemical characteristics, cellular uptake and intracellular trafficking of plasmid DNA/cationic liposome complexes and subsequent gene expression. J Control Release 2000; 66: 255-269.
26. Ileres D, Weibel JM, Heissler D, Zuber G, Duportail G, Mely Y. Dependence of the cellular internalization and transfection efficiency on the structure and physicochemical properties of cationic detergent,/ DNA/liposomes. J Gene Med 2004; 6: 415-428.
27. Yeeprae W, Kawakami S, Higuchi Y, Yamashita F, Hashida M. Biodistribution characteristics of mannosylated and fucosylated O/W emulsions in mice. J Drug Target 2005; 13: 479-487.
28. Yeeprae W, Kawakami S, Yamashita F, Hashida M. Effect of mannose density on mannose receptor-mediated cellular uptake of mannosylated O/W emulsions by macrophages. J Control Release 2006; 114: 193-201.
29. Stopeck AT, Jones & Hersh EM, et al. Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/ beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma. Clin Cancer Res 2001; 7: 2285-2291.
30. Nomura T, Nakajima S, Kawabata. K, Yamashita F, Takakura Y, Hashida M. Intratumoral pharmacokinetics and in vivo gene expression of naked plasmid DNA and its cationic liposome complexes after direct gene transfer. Cancer Res 1997; 57: 2681-2686.